Clinical Trials Browser

Phase 2/3 × Head and Neck Neoplasms × 90 days × Clear all

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07528495 2026-04-14

Eliminate

Phase 2/3 Recruiting

396 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06295731 2026-03-31

HexAgon-HN

Phase 2/3 Active not recruiting

410 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07353671 2026-03-25

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Phase 2/3 Recruiting

60 enrolled

Head & Neck

Head and Neck Neoplasms, Radiodermatitis

NCT06788990 2026-03-23

FORTIFI-HN01

Phase 2/3 Recruiting

650 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Camurati-Engelmann Syndrome, Head and Neck Neoplasms, Laryngeal Diseases

Clinical Trials

AHEAD-MERIT

Eliminate

HexAgon-HN

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

FORTIFI-HN01